Skip to main content
. 2014 Feb 13;8:227–237. doi: 10.2147/DDDT.S54956

Figure 1.

Figure 1

Plots of vendor assay correlations. (A) Coefficient of determination (r2) for each biomarker with assays from two vendors. (BI) are biomarkers with r2≥0.700 (B) Creatinine concentration, (C) NAG concentration, (D) creatinine concentration, (E) KIM-1 concentration, (F) NGAL concentration, (G) cystatin C concentration, (H) KIM-1 concentration normalized to creatinine, and (I) NGAL concentration normalized to creatinine.

Notes: 1Comparison between Central and Pacific Biomarker assays, both single analyte assays; 2comparison between Pacific Biomarker (single analyte) and Rules Based Medicine (multiplex) assays.

Abbreviations: KIM-1, kidney injury marker-1; NAG, N-acetyl-β-glucosaminidase; NGAL, neutrophil gelatinase-associated lipocalin.